Thu nhập trên mỗi cổ phiếu gần đây của THER so sánh thế nào với kỳ vọng?
Doanh thu của Theralink Technologies Inc THER trong quý trước như thế nào?
Ước tính doanh thu của Theralink Technologies Inc là bao nhiêu?
Điểm chất lượng thu nhập của Theralink Technologies Inc là bao nhiêu?
Theralink Technologies Inc báo cáo thu nhập khi nào?
Thu nhập dự kiến của Theralink Technologies Inc là bao nhiêu?
Theralink Technologies Inc có vượt kỳ vọng thu nhập không?
Thống kê chính
Giá đóng cửa trước
$0.0001
Giá mở cửa
$0.001
Phạm vi ngày
$0.0001 - $0.001
Phạm vi 52 tuần
$0.0001 - $0.001
Khối lượng
110
Khối lượng trung bình
0
EPS (TTM)
-0.00
Tỷ suất cổ tức
--
Vốn hóa thị trường
$615.1K
THER là gì?
Theralink Technologies, Inc. is a precision medicine company, which engages in the development of novel cancer immunotherapy products. The company is headquartered in Baton Rouge, Louisiana and currently employs 16 full-time employees. The company went IPO on 2007-04-23. The firm's technology, through its patented phosphoprotein and protein biomarker platform and lab developed tests (LDTs), targets multiple areas of oncology and drug development. Its LDT, the Theralink Assay for Breast Cancer, is utilized by oncologists across the United States to assist in making the targeted treatment plan for their patients with advanced breast cancer. The firm is also working on a second assay for advanced breast cancer that is planned to be pan-tumor for solid tumors across multiple tumor types, such as ovarian, endometrial, liver, head and neck, colorectal, lung, and prostate, among others. The company provides precision oncology data through its Theralink Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to both Food and Drug Administration approved and investigational drug treatments.